An2 Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in An2 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including An2 Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in An2 Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $328k | 68k | 4.84 |
| 2023-03-31 | $313k | 32k | 9.87 |
| 2022-12-31 | $295k | 31k | 9.55 |
| 2022-09-30 | $0 | 14k | 0.00 |